Log in to save to my catalogue

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108305

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

About this item

Full title

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

Publisher

Cham: Springer International Publishing

Journal title

Cellular and molecular life sciences : CMLS, 2016-08, Vol.73 (15), p.2871-2896

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Sirtuins are an evolutionary conserved family of NAD
+
-dependent protein lysine deacylases. Mammals have seven Sirtuin isoforms, Sirt1–7. They contribute to regulation of metabolism, stress responses, and aging processes, and are considered therapeutic targets for metabolic and aging-related diseases. While initial studies were focused on Si...

Alternative Titles

Full title

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108305

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11108305

Other Identifiers

ISSN

1420-682X

E-ISSN

1420-9071

DOI

10.1007/s00018-016-2180-7

How to access this item